Dr. Daniel C. Griffis, MD

Dr. Griffis practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Griffis' NPI, 1063499010, was assigned on December 29, 2005. Dr. Griffis graduated from University of Texas Southwestern Medical School at Dallas in 2003. Dr. Griffis holds Texas license L9711.

Dr. Griffis' primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Griffis' primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Griffis to 1 more medical group, named with a free account. Dr. Griffis' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Griffis practices. Vendor and product names are available with a free account.

Family medicine is Dr. Griffis' primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Griffis is licensed in Texas.

CMS data shows 127 Medicare services from Dr. Griffis across 2 procedure codes in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $8,171 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Griffis in 2024. The largest group is 65 to 74, with 28 patients. 65% of them have high blood pressure, and 40% have arthritis. 53% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Griffis' median patient age at 68, with 42% women.

In 2024, Dr. Griffis wrote 1,567 Medicare Part D claims for 94 patients. 87% of them were for generic drugs. CMS names the drug for 1,245 of them, across 52 drugs with 11 or more claims each, at $91,432 in total drug cost. In 2023, CMS named 2,253 claims across 71 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Griffis for performance year 2024, reported as part of a group. Dr. Griffis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Griffis from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Meridian Bioscience Inc. paid the most, $11.

Dr. Griffis graduated from University of Texas Southwestern Medical School at Dallas in 2003.